Page 335 - Eshre Final Programme 2015

IBSA Company Symposium
Tuesday, 16 June 2015 I Room Lisbon I 11:45 - 13:00
Stereochemistry and isoforms: Influence of the formulation of gonadotrophins on ART Chairmen: M. Filicori (Italy) and R. Scott (USA)
11:45 Welcome and introduction
11:50 FSH action during the follicular phase of the natural cycle - C.Y. Andersen (Denmark)
12:10 hCGs: different sources of production, different glycoforms and functions - T. Fournier (France)
12:30 Safety and efficacy of a new HMG preparation: results of the European multi-centre trial - G. Lockwood (United Kingdom)
12:50 Discussion and conclusion 13:00 End of session
MSD Company Symposium
Tuesday, 16 June 2015 I Room Lisbon I 14:00 - 15:15
“Optimizing Patient Outcomes toward a More Efficient Clinic” Chair: Professor William Ledger (Australia)
14:00 Chairman’s Welcome and Opening Remarks - William Ledger (Australia)
14:10 How to Optimize Patient Reported Outcomes in Clinics with a Large Number of IVF Cycles (20 min) - Jie Qiao (People’s Republic of China)
14:30 New Technologies May Improve Patient Success Rates: How to Integrate into Practice - Carlos Simón (Spain)
14:50 Efficient Controlled Ovarian Stimulation: Patient and Clinic Centricity – William Ledger (Australia)
15:10 Chair’s Closing Remarks - William Ledger (Australia)
Pierre Fabre Médicament Company Symposium Tuesday, 16 June 2015 I Room Évora I 17:00 - 18:15
"Pregnancy Management: Beliefs and science”
• Introduction - Nils Milman (Denmark)
• Dietary habits: investigate! - Tomasz Paszkowski (Poland)
• Supplementation: a medical issue - Irene Cetin (Italy)
• Which iron for pregnant women? - Camil Castelo-Branco (Spain)
• Questions and conclusion - Nils Milman (Denmark)
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 335
ACKNOWLEDGEMENTS